Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

19 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
An Allosteric Inhibitor Scaffold Targeting the PIF-Pocket of Atypical Protein Kinase C Isoforms.
Arencibia JM, Fröhner W, Krupa M, Pastor-Flores D, Merker P, Oellerich T, Neimanis S, Schmithals C, Köberle V, Süß E, Zeuzem S, Stark H, Piiper A, Odadzic D, Schulze JO, Biondi RM. Arencibia JM, et al. Among authors: koberle v. ACS Chem Biol. 2017 Feb 17;12(2):564-573. doi: 10.1021/acschembio.6b00827. Epub 2017 Jan 13. ACS Chem Biol. 2017. PMID: 28045490
Single measurement of hemoglobin predicts outcome of HCC patients.
Finkelmeier F, Bettinger D, Köberle V, Schultheiß M, Zeuzem S, Kronenberger B, Piiper A, Waidmann O. Finkelmeier F, et al. Among authors: koberle v. Med Oncol. 2014 Jan;31(1):806. doi: 10.1007/s12032-013-0806-2. Epub 2013 Dec 11. Med Oncol. 2014. PMID: 24326985
Biodegradable human serum albumin nanoparticles as contrast agents for the detection of hepatocellular carcinoma by magnetic resonance imaging.
Watcharin W, Schmithals C, Pleli T, Köberle V, Korkusuz H, Huebner F, Zeuzem S, Korf HW, Vogl TJ, Rittmeyer C, Terfort A, Piiper A, Gelperina S, Kreuter J. Watcharin W, et al. Among authors: koberle v. Eur J Pharm Biopharm. 2014 May;87(1):132-41. doi: 10.1016/j.ejpb.2013.12.010. Epub 2013 Dec 21. Eur J Pharm Biopharm. 2014. PMID: 24365328
Improving Drug Penetrability with iRGD Leverages the Therapeutic Response to Sorafenib and Doxorubicin in Hepatocellular Carcinoma.
Schmithals C, Köberle V, Korkusuz H, Pleli T, Kakoschky B, Augusto EA, Ibrahim AA, Arencibia JM, Vafaizadeh V, Groner B, Korf HW, Kronenberger B, Zeuzem S, Vogl TJ, Waidmann O, Piiper A. Schmithals C, et al. Among authors: koberle v. Cancer Res. 2015 Aug 1;75(15):3147-54. doi: 10.1158/0008-5472.CAN-15-0395. Cancer Res. 2015. PMID: 26239478
Tax1BP1 limits hepatic inflammation and reduces experimental hepatocarcinogenesis.
Waidmann O, Pleli T, Weigert A, Imelmann E, Kakoschky B, Schmithals C, Döring C, Frank M, Longerich T, Köberle V, Hansmann ML, Brüne B, Zeuzem S, Piiper A, Dikic I. Waidmann O, et al. Among authors: koberle v. Sci Rep. 2020 Oct 1;10(1):16264. doi: 10.1038/s41598-020-73387-4. Sci Rep. 2020. PMID: 33004985 Free PMC article.
19 results